Энергия мозга. Теория развития всех психических заболеваний, объясняющая их общую причину

8. M. Olfson, S. C. Marcus, and J. G. Wan. “Treatment Patterns for Schizoaffective Disorder and Schizophrenia Among Medicaid Patients.” Psychiatr Serv 60 (2009): 210–216. doi: 10.1176/ps.2009.60.2.210.

9. Seth Himelhoch, Eric Slade, Julie Kreyenbuhl, Deborah Medoff, Clayton Brown, and Lisa Dixon. “Antidepressant Prescribing Patterns Among VA Patients with Schizophrenia.” Schizophr Res 136(1) (2012): 32–35. doi: 10.1016/j.schres.2012.01.008.

10. P. D. Harvey, R. K. Heaton, W. T. Carpenter Jr., M. F. Green, J. M. Gold, and M. Schoenbaum. “Functional Impairment in People with Schizophrenia: Focus on Employability and Eligibility for Disability Compensation.” Schizophr Res 140(1–3) (2012): 1–8. doi: 10.1016/j.schres.2012.03.025.

11. L. L. Judd, H. S. Akiskal, P. J. Schettler, et al. “The Long-Term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder.” Arch Gen Psychiatry 59(6) (June 2002): 530–537. doi: 10.1001/archpsyc.59.6.530.

12. “Biomarkers Outperform Symptoms in Parsing Psychosis Subgroups.” National Institutes of Health. December 8, 2015. htps://www.nih.gov/news-events/news-releases/biomarkers-outperform-symptoms-parsing – psychosis-subgroups.

13. Maurice M. Ohayon and Alan F. Schatzberg. “Prevalence of Depressive Episodes with Psychotic Features in the General Population.” Am J Psychiatry 159(11) (2002): 1855–1861. doi: 10.1176/appi.ajp.159.11.1855.

14. B. Bandelow and S. Michaelis. “Epidemiology of Anxiety Disorders in the 21st Century.” Dialogues Clin Neurosci 17(3) (2015): 327–335. doi: 10.31887/DCNS.2015.17.3/bbandelow.

15. O. Plana-Ripoll, C. B. Pedersen, Y. Holtz, et al. “Exploring Comorbidity Within Mental Disorders Among a Danish National Population.” JAMA Psychiatry 76(3) (2019): 259–270. doi: 10.1001/ jamapsychiatry.2018.3658.

16. R. C. Kessler, W. T. Chiu, O. Demler, and E. E. Walters. “Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication.” Arch Gen Psychiatry 62(6) (2005): 617–627. doi: 10.1001/archpsyc.62.6.617.

17. M. C. Lai, C. Kassee, R. Besney, S. Bonato, L. Hull, W. Mandy, P. Szatmari, and S. H. Ameis. “Prevalence of Co-occurring Mental Health Diagnoses in the Autism Population: A Systematic Review and Meta-Analysis.” Lancet Psychiatry 6(10) (October 2019): 819–829. doi: 10.1016/S2215-0366(19)30289-5.

18. O. Plana-Ripoll, C. B. Pedersen, Y. Holtz, et al. “Exploring Comorbidity Within Mental Disorders Among a Danish National Population.” JAMA Psychiatry 76(3) (2019): 259–270. doi: 10.1001/ jamapsychiatry.2018.3658.

19. National Institute of Mental Health. “Eating Disorders.” National Institute of Mental Health, US Dept. of Health and Human Services. https://www.nimh.nih.gov/health/statistics/eating-disorders.shtml.

20. K. R. Merikangas, J. P. He, M. Burstein, S. A. Swanson, S. Avenevoli, L. Cui, C. Benjet, K. Georgiades, and J. Swendsen. “Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication – Adolescent Supplement (NCS-A).” J Am Acad Child Adolesc Psychiatry 49(10) (October 2010): 980–989. http://www.ncbi.nlm.nih.gov/pubmed/20855043/.

21. O. Plana-Ripoll, C. B. Pedersen, Y. Holtz, et al. “Exploring Comorbidity Within Mental Disorders Among a Danish National Population.” JAMA Psychiatry 76(3) (2019): 259–270. doi: 10.1001/ jamapsychiatry.2018.3658.

22. B. B. Lahey, B. Applegate, J. K. Hakes, D. H. Zald, A. R. Hariri, and P. J. Rathouz. “Is There a General Factor of Prevalent Psychopathology During Adulthood?” J Abnorm Psychol 121(4) (2012): 971–977. doi: 10.1037/a0028355.

23. Avshalom Caspi and Terrie E. Moffitt. “All for One and One for All: Mental Disorders in One Dimension.” Am J Psychiatry 175(9) (2018): 831–44. doi: 10.1176/appi.ajp.2018.17121383.

24. E. Pettersson, H. Larsson, and P. Lichtenstein. “Common Psychiatric Disorders Share the Same Genetic Origin: A Multivariate Sibling Study of the Swedish Population.” Mol Psychiatry 21 (2016): 717–721. doi: 10.1038/mp.2015.116.

25. A. Caspi, R. M. Houts, A. Ambler, et al. “Longitudinal Assessment of Mental Health Disorders and Comorbidities Across 4 Decades Among Participants in the Dunedin Birth Cohort Study.” JAMA Netw Open 3(4) (2020): e203221. doi: 10.1001/jamanetworkopen.2020.3221.

Глава 4

1. A. P. Rajkumar, H. T. Horsdal, T. Wimberley, et al. “Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People with Schizophrenia: A Danish Population-Based Cohort Study.” Am J Psychiatry 174 (2017): 686–694. doi: 10.1176/appi.ajp.2016.16040442.

2. B. Mezuk, W. W. Eaton, S. Albrecht, and S. H. Golden. “Depression and Type 2 Diabetes over the Lifespan: A Meta-Analysis.” Diabetes Care 31 (2008): 2383–2390. doi: 10.2337/dc08-0985.

3. K. Semenkovich, M. E. Brown, D. M. Svrakic, et al. “Depression and Diabetes.” Drugs 75(6) (2015): 577.doi: 10.1007/s40265-015-0347-4.